Rocky Ganske
Direktor/Vorstandsmitglied bei Xceed Molecular Corp.
Profil
Rocky Ganske is the founder of Genomic Utilities LLC.
He is currently the Director at Xceed Molecular Corp.
Previously, he was the Chief Executive Officer at CellAegis Devices, Inc. from 2014 to 2020.
He was also the President & Chief Executive Officer at Illumisonics, Inc. and the Chief Operating Officer at Third Wave Technologies, Inc. Additionally, he served as the President & Chief Operating Officer at Axela, Inc. from 2009 to 2010.
Mr. Ganske received his undergraduate degree from the University of Utah.
Aktive Positionen von Rocky Ganske
Unternehmen | Position | Beginn |
---|---|---|
Xceed Molecular Corp.
Xceed Molecular Corp. Medical SpecialtiesHealth Technology Xceed Molecular Corporation is a molecular diagnostic company dedicated to commercializing a platform for automated gene expression analysis and developing proprietary clinical research assays and custom arrays. They develop tools and content aimed at accelerating the current market trend towards 'translational medicine', and bridging the gap from gene signature validation to clinical diagnostics. The Ziplex Automated Workstation is the first integrated and fully automated hybridization system for multiplex gene expression signatures. Their integrated solution - the Ziplex System - features this innovative instrument platform and focused-content TipChip arrays and reagents to perform highly multiplexed molecular assays with superior accuracy, reproducibility, speed and scalability. The Ziplex System is designed to provide the ease-of-use in assay automation and analytics that is required to successfully translate gene expression analysis from research use into routine practice. Xceed complements the Ziplex platform by offering Gene Expression Services and Assay Development Services. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Rocky Ganske
Unternehmen | Position | Ende |
---|---|---|
CellAegis Devices, Inc.
CellAegis Devices, Inc. Electronic Equipment/InstrumentsElectronic Technology CellAegis Devices, Inc. develops device for the treatment of cardiac patients. . It offers autoRIC Device, an automated noninvasive device that provides point of care delivery of remote ischemic conditioning. The company was founded by John Berton, Andrew N. Redington and Christopher Caldarone and is headquartered in Toronto, Canada. | Vorstandsvorsitzender | 01.06.2020 |
Illumisonics, Inc.
Illumisonics, Inc. Medical DistributorsDistribution Services Illumisonics, Inc. develops and patents advanced optical imaging systems for pre-clinical and clinical applications. The company was founded in 2014 and is based in Waterloo, Canada, where it has offices and R&D facilities. Illumisonics' executive team has a track record of successfully building companies and improving outcomes for clinicians and patients. The Canadian company's technical R & D teams are pioneers in pars technology, which captures all light-matter interactions to yield unprecedented cellular and molecular information. Illumisonics works with market-leading partners to develop systems for specific applications. The company's goal is to enable medical personnel to drive better healthcare outcomes for patients while enhancing decision-making and reducing costs. The company was founded by Parsin Haji Reza, and the CEO is Scott C. Durbin. | Vorstandsvorsitzender | - |
Genomic Utilities LLC | Gründer | - |
Third Wave Technologies, Inc.
Third Wave Technologies, Inc. BiotechnologyHealth Technology Third Wave Technologies, Inc. developed DNA and RNA detection technology. It provided molecular solutions for clinical, research, and agricultural customers. The company was founded in February 1993 and was headquartered in Madison, WI. | Geschäftsführer | - |
Axela, Inc.
Axela, Inc. Medical SpecialtiesHealth Technology Axela, Inc. develops biosensor technology. It offers next generation, commercial stage, multiplex tools that provide enhanced analysis of proteins, DNA and RNA. The firm’s products include Ziplex System, autograph, metabolic, colon and breast cancer, inflammation Xpress chips, diffractive optics technology and sensors, dotLab mX System and dot-Avidin, Ready and Covalent products. The company was founded by M. Cynthia Goh, Richard Loo, B. Jane Goh and Richard McAloney in 2001 and is headquartered in Toronto, Canada. | Vorstandsvorsitzender | - |
Ausbildung von Rocky Ganske
University of Utah | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 6 |
---|---|
Axela, Inc.
Axela, Inc. Medical SpecialtiesHealth Technology Axela, Inc. develops biosensor technology. It offers next generation, commercial stage, multiplex tools that provide enhanced analysis of proteins, DNA and RNA. The firm’s products include Ziplex System, autograph, metabolic, colon and breast cancer, inflammation Xpress chips, diffractive optics technology and sensors, dotLab mX System and dot-Avidin, Ready and Covalent products. The company was founded by M. Cynthia Goh, Richard Loo, B. Jane Goh and Richard McAloney in 2001 and is headquartered in Toronto, Canada. | Health Technology |
Xceed Molecular Corp.
Xceed Molecular Corp. Medical SpecialtiesHealth Technology Xceed Molecular Corporation is a molecular diagnostic company dedicated to commercializing a platform for automated gene expression analysis and developing proprietary clinical research assays and custom arrays. They develop tools and content aimed at accelerating the current market trend towards 'translational medicine', and bridging the gap from gene signature validation to clinical diagnostics. The Ziplex Automated Workstation is the first integrated and fully automated hybridization system for multiplex gene expression signatures. Their integrated solution - the Ziplex System - features this innovative instrument platform and focused-content TipChip arrays and reagents to perform highly multiplexed molecular assays with superior accuracy, reproducibility, speed and scalability. The Ziplex System is designed to provide the ease-of-use in assay automation and analytics that is required to successfully translate gene expression analysis from research use into routine practice. Xceed complements the Ziplex platform by offering Gene Expression Services and Assay Development Services. | Health Technology |
Third Wave Technologies, Inc.
Third Wave Technologies, Inc. BiotechnologyHealth Technology Third Wave Technologies, Inc. developed DNA and RNA detection technology. It provided molecular solutions for clinical, research, and agricultural customers. The company was founded in February 1993 and was headquartered in Madison, WI. | Health Technology |
CellAegis Devices, Inc.
CellAegis Devices, Inc. Electronic Equipment/InstrumentsElectronic Technology CellAegis Devices, Inc. develops device for the treatment of cardiac patients. . It offers autoRIC Device, an automated noninvasive device that provides point of care delivery of remote ischemic conditioning. The company was founded by John Berton, Andrew N. Redington and Christopher Caldarone and is headquartered in Toronto, Canada. | Electronic Technology |
Genomic Utilities LLC | |
Illumisonics, Inc.
Illumisonics, Inc. Medical DistributorsDistribution Services Illumisonics, Inc. develops and patents advanced optical imaging systems for pre-clinical and clinical applications. The company was founded in 2014 and is based in Waterloo, Canada, where it has offices and R&D facilities. Illumisonics' executive team has a track record of successfully building companies and improving outcomes for clinicians and patients. The Canadian company's technical R & D teams are pioneers in pars technology, which captures all light-matter interactions to yield unprecedented cellular and molecular information. Illumisonics works with market-leading partners to develop systems for specific applications. The company's goal is to enable medical personnel to drive better healthcare outcomes for patients while enhancing decision-making and reducing costs. The company was founded by Parsin Haji Reza, and the CEO is Scott C. Durbin. | Distribution Services |